Facebook Employees Stage Virtual Walkout Over Handling of Trump Posts 
 

The action marks opposition to Mark Zuckerberg's decision to allow a post from President Trump about the recent social unrest that they believed violated the company's rules about inciting violence.


 
Music Labels Suspend Work in Support of Demonstrations 
 

Musicians and entertainment executives are encouraging workers to take Tuesday as a chance to reflect on racism in the country, in some cases even if that means taking off work.


 
CEOs and Big Businesses Speak Out on Racism, Police Violence 
 

Business leaders are speaking out about social injustice and racial inequality in the wake of George Floyd's death at the hands of police and the protests in more than 100 U.S. cities the fatal event has sparked.


 
Stitch Fix to Lay off About 1,400 Employees in California 
 

Stitch Fix, a personal-shopping service and clothing retailer, notified its roughly 1,400 California-based stylists Monday, or about 18% of its total staff, that they will be losing their jobs.


 
Starbucks Reduces Worker Hours to Reflect Pared-Back Operations 
 

The coffee chain is reducing labor as coronavirus limits hours and services.


 
Volkswagen Closes Argo AI Investment 
 

Volkswagen has closed a $2.6 billion investment in Argo AI, in a move that will facilitate the Pittsburgh-based self-driving startup's expansion in Europe.


 
Bain Capital, Cyrus Capital Are Preferred Bidders for Virgin Australia 
 

Investment firms Bain Capital and Cyrus Capital Partners have emerged as the preferred bidders for the assets of Virgin Australia Holdings Ltd., Australia's second-biggest airline which had filed for insolvency.


 
ANZ Sells NZ Asset Finance Business to Shinsei Bank 
 

Australia and New Zealand Banking Group Ltd. has agreed to sell its New Zealand asset finance business, UDC Finance, to Shinsei Bank Ltd., as the Australian bank continues with plans to streamline its operations.


 
Gun Stocks Surge Past Broader Market 
 

Shares of gun manufacturers soared Monday, continuing this year's winning streak.


 
Don't Expect Pfizer's Bad Reaction to Last 
 

A surprise cancer-drug failure will sting, but not as much as investors expect.